On one hand, FBXO9 is responsible for ubiquitination-mediated degradation of TEL2 and TTI1, which leads to the downregulation of mTORC1 signaling pathway and the inhibition of MM cell growth. The gene discussed is FBXO9; the disease is Miyoshi myopathy.